- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 12, 2026 | 5.36M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 448.08K sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 59.04K sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$2.28M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$1.44M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.41M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $2.84M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $4.24M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $3.64M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $4.69M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $658.6K |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $952.49K |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $662.25K |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $966.96K |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.52M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $3.3M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $3.5M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $5.2M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$5.09 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$29.69 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$5.09 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$29.69 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $789.08K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $630.89K |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $284.98K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $396.7K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$2.28M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$1.75M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$2.29M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$1.75M |
| Revenue | Q1 2026 · Mar 31, 2026 | $0 |
| Revenue | Q1 2026 · Mar 31, 2025 | $0 |